ARCHIVES

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Functional Imaging Centers Grant Program Approved By Advisors

December 11, 1998

First Lady Helps Dedicate New MDA Facilities

October 15, 1976

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982

Tucson Conference Could Be Lively

February 16, 1979

Clinical Trials Approved By NCI CTEP Last Month

April 29, 2011

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992